| Dr Amazair Mcallister Iii, MD | |
|
6145 Troost Ave, Kansas City, MO 64110-3435 | |
| (816) 361-3159 | |
| (816) 361-3490 |
| Full Name | Dr Amazair Mcallister Iii |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 6145 Troost Ave, Kansas City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679841878 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 2000146118 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amazair Mcallister Iii, MD 6145 Troost Ave, Kansas City, MO 64110-3435 Ph: (816) 361-3159 | Dr Amazair Mcallister Iii, MD 6145 Troost Ave, Kansas City, MO 64110-3435 Ph: (816) 361-3159 |
News Archive
Researchers at The University of Texas M. D. Anderson Cancer Center and the National Cancer Institute have found that an experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma, even though prior therapy had eliminated virtually all of the B cells thought necessary to mount such a defense.
The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the initiation of an international Phase II study designed to assess the efficacy and safety of MSB0010718C, an investigational fully human IgG1 monoclonal antibody that binds to programmed death-ligand 1 (PD-L1).
With the summer edition of JAMIA-currently online at www.JAMIA.org-AMIA's peer-reviewed journal on informatics in biomedicine and health opens the door to translational science, highlighting several perspectives and five research articles on translational bioinformatics (TBI), and suggesting that future publications in greater volume will help keep JAMIA readers abreast of new developments and applications of translational bioinformatics, just as more hospital and academic health centers are embracing molecular measurements for diagnosis and planning therapies.
› Verified 9 days ago
Arthur Paul Greenberg, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2004 Nw 82nd Ct, Kansas City, MO 64151 Phone: 573-819-4992 | |
Dr. Nancy Rae Coates, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 114 W Gregory Blvd, Suite 200, Kansas City, MO 64114 Phone: 816-523-4600 Fax: 816-523-4724 | |
Dr. Shraddha Lohani, MD-AP General Practice Medicare: Medicare Enrolled Practice Location: 13013 Fuller Ave, Grandview, Mo, Kansas City, MO 63040 Phone: 360-433-1325 | |
Dr. David L Moore, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 650 E 25th St, Kansas City, MO 64108 Phone: 816-235-2100 | |
Dr. April Renee Due, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 3100 Emanuel Cleaver Ii Blvd, Kansas City, MO 64130 Phone: 816-923-2341 | |
Dr. Charles Thomas Spencer Iii, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 314-324-1724 | |
Steven D. Foote, DO General Practice Medicare: Accepting Medicare Assignments Practice Location: 7900 Lees Summit Rd, Kansas City, MO 64139 Phone: 816-404-7650 |